Research location
Wilton Manors
Florida, United States
Advertisement
Research activity in Wilton Manors
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 20 trials and 20 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wilton Manors
20 linked trials · page 1 of 1REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidENCT07476339 · 2026-06-17 · 1 site observation
RECRUITING
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV TreatmentNCT02707601 · 2016-04-01 · 1 site observation
COMPLETED
Attachment Inhibitor Comparison in Heavily Treatment Experienced PatientsNCT02362503 · 2015-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected AdultsNCT02345226 · 2015-01-26 · 1 site observation
COMPLETED
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)NCT02345252 · 2015-01-26 · 1 site observation
COMPLETED
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV InfectionNCT02038881 · 2014-04-28 · 1 site observation
COMPLETED
Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced AdultsNCT01967940 · 2013-10-25 · 1 site observation
COMPLETED
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal ImpairmentNCT01818596 · 2013-03-27 · 1 site observation
COMPLETED
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®NCT01579695 · 2013-02-01 · 1 site observation
TERMINATED
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®NCT01591902 · 2012-06-01 · 1 site observation
TERMINATED
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1NCT01345630 · 2011-09-01 · 1 site observation
TERMINATED
Safety and Tolerability of Crofelemer for HIV-Associated DiarrheaNCT01374490 · 2011-06-07 · 1 site observation
COMPLETED
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis BNCT01327547 · 2011-05-18 · 1 site observation
COMPLETED
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive AdultsNCT01231516 · 2010-10-26 · 1 site observation
COMPLETED
A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)NCT01102972 · 2010-04-01 · 1 site observation
COMPLETED
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsNCT00782301 · 2009-03-01 · 1 site observation
WITHDRAWN
Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)NCT01327898 · 2008-11-01 · 1 site observation
COMPLETED
Prospective Observational Epidemiologic Study of Maraviroc's SafetyNCT00665561 · 2008-03-31 · 1 site observation
COMPLETED
VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ PatientsNCT00561925 · 2007-11-01 · 1 site observation
COMPLETED
Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaNCT00547898 · 2007-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.